Season 2, Episode 4
Preparing your Disaster Plan in Digital Pathology
This episode's guests: Elizabeth Neyens, DVM, DABT
Our guest is Elizabeth Neyens, DVM, DABT
Is your lab or institution ready for a disaster?
Dr. Elizabeth Neyens has over 15 years of experience in translational drug development and has held various staff pathology positions in contract research organizations, the pharmaceutical industry and as well as research institutes worldwide.
Dr. Neyens currently supports academia, biotechnology and pharmaceutical companies with a variety of nonclinical services at Flanders ToxPath Consulting. She is an active scientist on social media and keeps a blog and has been a regular on podcasts about Pathology & Toxicology.
We are talking about preparing your disaster plan in digital pathology. What is data integrity and why is it important? How do we keep our data safe? What types of threats do we face in the areas of drug development and digital pathology?
We talk about cloud computing - the bad, the good and the ugly. And how can we prepare for the unexpected such as climate disasters and pandemics where stakeholders are suddenly shifted from an office environment to working from home?
More About Elizabeth Neyes, DVM, DABT
Dr. Elizabeth Neyens, DVM, DABT, Toxicological Pathologist
Dr. Elizabeth Neyens graduated from the University of Veterinary Medicine in Belgium and completed a 5-year internship & residency program in veterinary anatomic pathology at the University of Utrecht in the Netherlands. She received twice a first research award and was elected as best junior lecturer in Pathobiology. She is a Diplomate of the American College of Toxicologists since 2015 and an active member of the Society of Toxicologic Pathology (STP), the European Society of Toxicological Pathology (ESTP), the American College of Toxicologists (ACT) and Society of Quality Assurance Professionals (SQA) with whom she completed a successful QA mentee-mentorship program. In 2018, she certified in Digital Pathology in collaboration with the National Society of Histotechnology (NSH) & Digital Pathology Association (DPA). Elizabeth has 15-years of experience in translational drug development and held various staff pathology positions in CRO, Pharmaceuticals and Research Institutes worldwide. In 2018, she founded ElizabethToxPath-Consulting Inc.: A Preclinical Consultancy firm offering Anatomic-Pathology & Toxicology services. She focuses on nonclinical drug development, ocular toxicological pathology and digital pathology. She supports Academia, Biotechnology & Pharmaceuticals with a variety of nonclinical services including vaccine development. She is an active scientist on social media and keeps a blog with regular podcasts about Pathology & Toxicology.